Amarin Corp Plc (AMRN)

[Biobillionair]

STRENGTH trial update:
It's updated with new information each month, except April 2017.
https://clinicaltrials.gov/ct2/show/NCT02104817?term=epanova&rank=5

Vascepa mechanism of action trial updated April 2017.
Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects
This study has been terminated.
April 12, 2017
https://clinicaltrials.gov/ct2/show/NCT02422446?term=vascepa&rank=9

Let me be clear, AZN can not pass an FTC investigation to make any offer to Amarin at anytime before or after REDUCE-IT.

Gottlieb will open an investigation into Amarin's regulatory treatment. This investigation will include the FBI looking into the potential out of agency collusions that could have take place between the industry, DMEP, and Office of New Drugs director. The STRENGTH trial director has protested "fish-oil" too much, it just looks suspicious he'd really be interested in conducting a trial to prove anything.

Amarin backing out of ANCHOR SPA appeal has never make sense unless they where promised quid pro quo, with a promise everything would be OK for "them" in the end. When's the end? Far enough out for us to forget the case that's clearly laid out in Amarin's 2017 proxy statement.
http://investor.amarincorp.com/secfiling.cfm?filingID=1193125-17-131308&CIK=897448

Had Amarin fully prosecuted the ANCHOR rescission, which was strong enough to win First Law suit, none of the above speculations would be concerning. Instead, we have Amarin potentially involved in collusion....? Without the ANCHOR SPA rescission being corrected Amarin everyone makes out fine except for diluted longs that purchase this stock before October 16th 2013. If Amarin doesn't hold the FDA accountable they risk being accountable for their inactions.

Amarin will never have a clear path to success until fully prosecuting ANCHOR rescission. 'We're afraid of the FDA' isn't going to cut it with a Federal Judge that can look on Amarin's two prior Federal Court Cases against the FDA. Amarin backed off FDA, not out of fear, but out of promises like the 80% interim. Nothing that would return value to stakeholders prior to misdeeds. The PDUFA date is not even in the foreseeable future.

Will JT address the horrible stock price tomorrow? You can bet your Irish balls he will NOT!

BB